Mahmood Mahmood HassanHassan,, MDMD,, PhPh..DD..
Diversified Career inDiversified Career in Neurosurgery Neurosurgery
accross Continents accross Continents
Dhaka Medical Dhaka Medical GraduateGraduate
DMC played a pioneering role DMC played a pioneering role in medical science in medical science development , development , health care delivery &health care delivery &in nation building activitiesin nation building activities
Post Graduation from Post Graduation from KUKU
Residency TrainingResidency Training
• Full time residentialFull time residential• Advance Clinical training with medico legal Advance Clinical training with medico legal protectionprotection• Earned PhD degree with 11 required creditsEarned PhD degree with 11 required credits• Attended all annual neurosurgical meetings Attended all annual neurosurgical meetings activelyactively• Played active role in NUYNA Played active role in NUYNA • Published several papers Published several papers • Flew to Edinburgh, UK to Flew to Edinburgh, UK to attend attend Miller memorial meetingMiller memorial meeting• Accepted by Harvard University Accepted by Harvard University for fellowship for fellowship
Works on NPH & Shunt Works on NPH & Shunt ValveValve
MGH: Top of the worldMGH: Top of the world
http://neurosurgery.mgh.harvard.edu/fellows/hassan
In MGH, BostonIn MGH, Boston
MGH ExperienceMGH Experience
• Attended breakfast Attended breakfast meetings meetings in Ether Domein Ether Dome• Observed surgical Observed surgical proceduresprocedures• Went to Children Hospital &Went to Children Hospital & Brigham Women’s Hospital Brigham Women’s Hospital • Approved with permanent Approved with permanent residency statusresidency status• Attended CNS meeting, 1998Attended CNS meeting, 1998
to receive to receive International International FellowshipFellowship award award
• Published paper on strokePublished paper on stroke
Published paper on Published paper on strokestroke
(TTC)-stained coronalsections
Reduction in infarct volumes independent administration of Mexiletine (60 mg/kg, i.p.) or Magnesium (Mg++, 90 mg/kg, i.a.).
Infarcts are observed (pale region) representativeof the MCA perfusion region
Summary
Mexiletine protects against focal cerebral ischemia, when administered up to 30 min after the onset of permanent MCA occlusion
Did not favor the concurrent use of Mexiletine plus Mg21 for limiting brain injury induced by permanent MCA occlusion
WhereWhereExcellence in the disciplineExcellence in the discipline
Achieved well…..Achieved well…..
High Speed drill WorkshopHigh Speed drill Workshop
Paper Published in Neurosurgery Paper Published in Neurosurgery
Mentor of MentorsMentor of Mentors
Practicing Practicing in Tucsonin Tucson
Returning to help Returning to help people people
Pledged to give my Pledged to give my all…all…